{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:34:10Z","timestamp":1794396850474,"version":"4.9.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"name":"National Heart, Lung, and Blood Institute","award":["R01HL176836"],"award-info":[{"award-number":["R01HL176836"]}],"id":[{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To provide real-world data to inform benchmarking goals and practical issues that influence optimal antenatal corticosteroid timing and to examine patient factors, such as gestational age at steroid administration and presenting diagnoses, associated with steroid administration in relation to delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This is a retrospective cohort study of singleton deliveries between July 1, 2016, and December 31, 2024, at two large academic hospitals with level IV neonatal intensive care units in a single health system. The primary cohort of interest was individuals who delivered between 24 0\/7 and 33 6\/7 weeks of gestation. The primary outcome of interest was the timing of antenatal corticosteroid administration in relation to delivery, categorized as none, delivery between 6 hours and 7 days after the first dose of antenatal corticosteroid (\u201coptimally timed\u201d per the Society for Maternal-Fetal Medicine\u2019s quality metric), and delivery less than 6 hours or more than 7 days after the first dose of antenatal corticosteroid (\u201csuboptimally timed\u201d). As a balancing measure to optimally timed antenatal corticosteroid administration, we also examined those who received antenatal corticosteroids before 34 weeks of gestation and delivered at term (after 37 weeks). We reported the rates of optimal timing and term delivery by their corresponding weeks of gestation and performed multivariable logistic regression modeling to understand patient factors and diagnoses associated with antenatal corticosteroid timing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Among the 1,694 pregnant patients who delivered before 34 weeks of gestation, 961 (56.7%) had optimally timed antenatal corticosteroid administration, 162 (9.6%) received the first dose of antenatal corticosteroids less than 6 hours before delivery, 320 (18.9%) delivered more than 7 days after antenatal corticosteroid administration, and 251 (14.8%) did not receive antenatal corticosteroids. Of those who received antenatal steroids before 34 weeks of gestation, 747 of 2,879 (25.9%) delivered at term. There was little variation in optimal timing or term delivery by gestational age. Clinical factors associated with optimally timed antenatal corticosteroid administration compared with delivery more than 7 days after administration included pregnancy-related hypertensive disorder (adjusted odds ratio [aOR] 1.88, 95% CI, 1.31\u20132.69), preterm labor (aOR 2.78, 95% CI, 1.32\u20135.81), premature rupture of membranes (1.37, 95% CI, 1.33\u20131.42), anxiety disorder (aOR 079, 95% CI, 0.76\u20130.83), multiparous with no history of preterm birth (aOR 0.81, 95% CI, 0.77\u20130.86), placenta previa (aOR 0.76, 95% CI, 0.68\u20130.84), and placenta accreta (aOR 0.83, 95% CI, 0.81\u20130.85).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Achieving optimal timing of antenatal corticosteroid administration remains challenging. These findings underscore the need for improved prediction of preterm delivery and individualized patient assessment to ensure timely access to antenatal corticosteroids for women at risk of preterm birth while reducing unnecessary exposure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006178","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:00:21Z","timestamp":1770328821000},"page":"e33-e42","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Maximizing Benefit From Antenatal Steroid Use While Avoiding Overuse"],"prefix":"10.1097","volume":"148","author":[{"given":"Mark A.","family":"Clapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Reiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gyamfi-Bannerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali J.","family":"Kaimal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"R1-20260930","first-page":"CD004454","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"12","author":"McGoldrick","year":"2020","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R2-20260930","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajog.2018.04.007","article-title":"Antenatal corticosteroids: an assessment of anticipated benefits and potential risks","volume":"219","author":"Jobe","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20260930","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1990.tb01711.x","article-title":"The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials","volume":"97","author":"Crowley","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"R4-20260930","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.1995.03520290065031","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes","volume":"273","author":"Gilstrap","year":"1995","journal-title":"JAMA"},{"key":"R5-20260930","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2022.02.021","article-title":"Patient Safety and Quality Committee. Society for Maternal-Fetal Medicine special statement: quality metrics for optimal timing of antenatal corticosteroid administration","volume":"226","author":"Hamm","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20260930","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.semperi.2017.08.010","article-title":"Racial and ethnic differences in preterm birth: a complex, multifactorial problem","volume":"41","author":"Manuck","year":"2017","journal-title":"Semin Perinatol"},{"key":"R7-20260930","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ajog.2020.07.015","article-title":"Racial disparities in the administration of antenatal corticosteroids in women with preterm birth","volume":"223","author":"Gulersen","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20260930","doi-asserted-by":"crossref","first-page":"101397","DOI":"10.1016\/j.ajogmf.2024.101397","article-title":"Sociodemographic factors associated with antenatal steroid use among late preterm births","volume":"6","author":"Clapp","year":"2024","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R9-20260930","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Antenatal corticosteroid therapy for fetal maturation. Committee Opinion No. 713. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R10-20260930","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"R11-20260930","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1080\/14767058.2019.1670159","article-title":"Missed opportunities for optimal antenatal corticosteroid timing in medically indicated preterm births","volume":"34","author":"Rottenstreich","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R12-20260930","doi-asserted-by":"crossref","first-page":"645.e1","DOI":"10.1016\/j.ajog.2014.11.021","article-title":"The timing of administration of antenatal corticosteroids in women with indicated preterm birth","volume":"212","author":"Adams","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20260930","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1055\/s-0040-1721495","article-title":"Timing of antenatal steroid administration and effects on the newborn infant: a retrospective study","volume":"39","author":"Taleghani","year":"2022","journal-title":"Am J Perinatol"},{"key":"R14-20260930","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/ijgo.14893","article-title":"Optimizing the timing of antenatal corticosteroid administration prior to anticipated preterm birth: a retrospective cohort study","volume":"163","author":"Danieli-Gruber","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"R15-20260930","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00404-021-06362-7","article-title":"Timing of antenatal corticosteroids in relation to clinical indication","volume":"306","author":"Smith","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"R16-20260930","doi-asserted-by":"crossref","first-page":"120.e1","DOI":"10.1016\/j.ajog.2015.08.018","article-title":"Antenatal corticosteroid timing: accuracy after the introduction of a rescue course protocol","volume":"214","author":"Makhija","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20260930","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/aogs.13439","article-title":"Patterns of use and optimal timing of antenatal corticosteroids in twin compared with singleton pregnancies","volume":"97","author":"Rottenstreich","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R18-20260930","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/1471-0528.13730","article-title":"Clinical indication and timing of antenatal corticosteroid administration at a single centre","volume":"123","author":"Levin","year":"2016","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"R19-20260930","first-page":"486","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"R20-20260930","doi-asserted-by":"crossref","first-page":"100955","DOI":"10.1016\/j.ajogmf.2023.100955","article-title":"A nomogram to optimize the timing of antenatal corticosteroids in threatened preterm delivery","volume":"5","author":"di Donato","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R21-20260930","doi-asserted-by":"crossref","first-page":"100077","DOI":"10.1016\/j.ajogmf.2019.100077","article-title":"Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes","volume":"2","author":"Battarbee","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R22-20260930","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1055\/a-1925-1435","article-title":"Obstacles to optimal antenatal corticosteroid administration to eligible patients","volume":"41","author":"Rood","year":"2024","journal-title":"Am J Perinatol"},{"key":"R23-20260930","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/AOG.0000000000000629","article-title":"Trends in optimal, suboptimal, and questionably appropriate receipt of antenatal corticosteroid prophylaxis","volume":"125","author":"Razaz","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R24-20260930","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1515\/jpm-2023-0353","article-title":"Trends in antenatal corticosteroid administration: did our timing improve?","volume":"52","author":"Rostin","year":"2024","journal-title":"J Perinat Med"},{"key":"R25-20260930","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12887-023-03887-5","article-title":"Effectiveness of antenatal dexamethasone in reducing respiratory distress syndrome and mortality in preterm neonates: a nested case control study","volume":"23","author":"Kibanga","year":"2023","journal-title":"BMC Pediatr"},{"key":"R26-20260930","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/j.semperi.2013.06.024","article-title":"Antenatal corticosteroids for periviable birth","volume":"37","author":"Wapner","year":"2013","journal-title":"Semin Perinatol"},{"key":"R27-20260930","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ogc.2022.10.006","article-title":"Antenatal steroids and tocolytics in pregnancy","volume":"50","author":"Pinson","year":"2023","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R28-20260930","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012","volume":"314","author":"Stoll","year":"2015","journal-title":"JAMA"},{"key":"R29-20260930","doi-asserted-by":"crossref","first-page":"e1508","DOI":"10.1542\/peds.2011-2216","article-title":"Approach to infants born at 22 to 24 weeks' gestation: relationship to outcomes of more-mature infants","volume":"129","author":"Smith","year":"2012","journal-title":"Pediatrics"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:03:45Z","timestamp":1790784225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006178","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"2025-10-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}